MedTrace Logo

Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis

NCT06082440 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-01-05

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells mediated by arthroscopy in patients with knee osteoarthritis. This experiment proposes to enroll 18-22 patients. The experimental drug is human umbilical cord mesenchymal stem cells.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

Human Umbilical Mesenchymal Stem Cells

Ntra-articular injection inject a corresponding dose of cells suspension into each joint cavity according to the lesion site.

Sponsors & Collaborators

  • First Affiliated Hospital of Wannan Medical College

    lead OTHER

Principal Investigators

  • Qiang Wang · First Affiliated Hospital of Wannan Medical College

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-22
Primary Completion
2025-08-15
Completion
2026-01-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06082440 on ClinicalTrials.gov